Measles-containing-vaccine second-dose (MCV2) immunization coverage in United Arab Emirates
United Arab Emirates: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 92.0% in 2025. ▬ Flat
Latest (2025)
92.0%
Change on year
unchanged
World rank
56th
of 194 countries
All-time high
99.0%
in 2014
All-time low
91.0%
in 2022
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in United Arab Emirates, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in United Arab Emirates stood at 92.0%.
That represents a change of down 7.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in United Arab Emirates peaked at 99.0% in 2014 and was at its lowest, 91.0%, in 2022.
That places United Arab Emirates 56th out of 194 countries with data for 2025, putting it in the middle of the range.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in United Arab Emirates, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 92.0% | — |
| 2001 | 92.0% | +0.0% |
| 2002 | 92.0% | +0.0% |
| 2003 | 92.0% | +0.0% |
| 2004 | 92.0% | +0.0% |
| 2005 | 94.0% | +2.2% |
| 2006 | 93.0% | -1.1% |
| 2007 | 93.0% | +0.0% |
| 2008 | 92.0% | -1.1% |
| 2009 | 93.0% | +1.1% |
| 2010 | 94.0% | +1.1% |
| 2011 | 95.0% | +1.1% |
| 2012 | 96.0% | +1.1% |
| 2013 | 98.0% | +2.1% |
| 2014 | 99.0% | +1.0% |
| 2015 | 99.0% | +0.0% |
| 2016 | 98.0% | -1.0% |
| 2017 | 97.0% | -1.0% |
| 2018 | 95.0% | -2.1% |
| 2019 | 94.0% | -1.1% |
| 2020 | 92.0% | -2.1% |
| 2021 | 96.0% | +4.3% |
| 2022 | 91.0% | -5.2% |
| 2023 | 94.0% | +3.3% |
| 2024 | 92.0% | -2.1% |
| 2025 | 92.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.5% | 92.0% | 94.0% | 10 |
| 2010s | 96.5% | 94.0% | 99.0% | 10 |
| 2020s | 92.8% | 91.0% | 96.0% | 6 |
Countries ranked near United Arab Emirates
More health data for United Arab Emirates
- Un projection of annual infant deaths, annual growth rate -0.3472 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 2.97 % change on previous year (2090)
- Heat deaths vs projected death rates 308.9 (2090)
- Un projection of annual infant deaths 287 (2100)
- Population ages 0-14, female, annual growth rate 4.71 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 0-14, female, per capita 0.0797 units per person (2025)
- Population ages 0-14, male, annual growth rate 3.16 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 0-14, male, per capita 0.0801 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in United Arab Emirates?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in United Arab Emirates was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in United Arab Emirates?
- The highest recorded value was 99.0% in 2014.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in United Arab Emirates?
- The lowest recorded value was 91.0% in 2022.
- How does United Arab Emirates rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- United Arab Emirates ranks 56th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in United Arab Emirates?
- Over the last ten years it is down 7.1%. The long-run trend across the full record is flat.
- Where does this United Arab Emirates data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).